Literature DB >> 13357693

Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.

R FRETER.   

Abstract

A method has been devised for inhibiting the normal enteric flora, permitting long term asymptomatic enteric infections of mice and guinea pigs with streptomycin-resistant strains of Shigella flexneri or Vibrio cholerae. Introduction of a streptomycin-resistant strain of E. coli into the intestinal tract of experimental animals resulted in a rapid elimination of the enteric pathogens studied. No in vitro production of antibiotic substances by this coli strain could be demonstrated. Active and oral passive immunization did not noticeably influence the number of Shigella or Vibrio organisms recoverable from the feces of infected animals.

Entities:  

Keywords:  CHOLERA/experimental; DYSENTERY, BACILLARY/experimental; ESCHERICHIA COLI

Mesh:

Year:  1956        PMID: 13357693      PMCID: PMC2136576          DOI: 10.1084/jem.104.3.411

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment.

Authors:  A R HIGGINS; T M FLOYD; M A KADER
Journal:  Am J Trop Med Hyg       Date:  1955-03       Impact factor: 2.345

2.  Cholera studies. IV. Problems in immunology.

Authors:  R POLLITZER; W BURROWS
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

3.  The fatal enteric cholera infection in the guinea pig, achieved by inhibition of normal enteric flora.

Authors:  R FRETER
Journal:  J Infect Dis       Date:  1955 Jul-Aug       Impact factor: 5.226

4.  Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection.

Authors:  M BOHNHOFF; B L DRAKE; C P MILLER
Journal:  Proc Soc Exp Biol Med       Date:  1954-05

5.  On the concept of direct antagonism in bacteria.

Authors:  E S WYNNE; J O NORMAN
Journal:  J Infect Dis       Date:  1953 Nov-Dec       Impact factor: 5.226

6.  Studies on immunity to Asiatic cholera. VI. Observations on the relation of antibody to effective immunity to experimental enteric cholera, with a note on sulfonamide therapy.

Authors:  W BURROWS
Journal:  J Infect Dis       Date:  1953 Mar-Apr       Impact factor: 5.226

7.  Studies on immunity to Asiatic cholera. VII. Prophylactic immunity to experimental enteric cholera.

Authors:  W BURROWS; L L WARE
Journal:  J Infect Dis       Date:  1953 Mar-Apr       Impact factor: 5.226

8.  Antibiotic Interrelationships among the Enteric Group of Bacteria.

Authors:  P Fredericq; M Levine
Journal:  J Bacteriol       Date:  1947-12       Impact factor: 3.490

9.  Coproantibody and bacterial antagonism as protective factors in experimental enteric cholera.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

  9 in total
  72 in total

1.  Estimation of growth rates of Escherichia coli BJ4 in streptomycin-treated and previously germfree mice by in situ rRNA hybridization.

Authors:  C U Rang; T R Licht; T Midtvedt; P L Conway; L Chao; K A Krogfelt; P S Cohen; S Molin
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Antibacterial mechanisms of the mouse gut. II. The role of Eh and volatile fatty acids in the normal gut.

Authors:  G G MEYNELL
Journal:  Br J Exp Pathol       Date:  1963-04

3.  Experimental intestinal colifrom infections in mice.

Authors:  F M ASHBURNER; R MUSHIN
Journal:  J Hyg (Lond)       Date:  1962-06

4.  [Mechanisms of nonspecific infection resistance].

Authors:  D BOHME
Journal:  Klin Wochenschr       Date:  1958-09-15

5.  Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs.

Authors:  S B FORMAL; G J DAMMIN; E H LABREC; H SCHNEIDER
Journal:  J Bacteriol       Date:  1958-05       Impact factor: 3.490

6.  In vivo change of serological specificity in Shigella flexneri.

Authors:  C D McGUIRE; T M FLOYD
Journal:  J Bacteriol       Date:  1958-07       Impact factor: 3.490

7.  Use of norfloxacin to study colonization ability of Escherichia coli in in vivo and in vitro models of the porcine gut.

Authors:  E M Nielsen; J Schlundt
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 8.  Probiotics in human medicine.

Authors:  R Fuller
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

9.  Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a.

Authors:  G H Rabbani; M J Albert; H Rahman; M Islam; D Mahalanabis; I Kabir; K Alam; M Ansaruzzaman
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Experimental Shigella infections. V. Studies in germ-free guinea pigs.

Authors:  S B FORMAL; G DAMMIN; H SPRINZ; D KUNDEL; H SCHNEIDER; R E HOROWITZ; M FORBES
Journal:  J Bacteriol       Date:  1961-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.